HIGHLIGHTS
- who: Kwangu0092 from the Osaka University, Japan have published the research work: A novel defined TLR3 agonist as an effective vaccine adjuvant, in the Journal: (JOURNAL)
- what: This study demonstrated that NVT is a homogeneous molecule with a confirmed molecular structure that enables accurate pharmacokinetic analysis.
- how: The result showed that the appearance concentration and molecular size of NVT were unaffected for 6 months .
SUMMARY
Vaccine adjuvants are substances that improve the efficacy of vaccines by helping induce strong protective immune_responses to vaccine antigens in humans or animals. Adjuvants . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.